Bromperidol
- Level
- Commodity
- Parent
- 51332500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51332505This classification denotes an antipsychotic agent with the molecular formula C21H23BrFNO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LYH6F7I22E, chemically known as 1-butanone, 4-(4-(4-bromophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)- but generally known as bromperidol, which bears US NIH Compound Identifier 2448. Bromperidol most often comes in base and decanoate forms. European Medicines Agency schedules Bromperidol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05923MIG. The term BROMPERIDOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules bromperidol in its Anatomical Therapeutic Chemical (ATC) Classification. BROMPERIDOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bromperidol under HS 29333999 and SITC 51574. As of Q4 2014, BROMPERIDOL remains the US FDA Preferred Term for this commodity. Bromperidol bears US NLM identifiers UMLS ID C0054138 and NCI Concept Code C76439. SMILES: BRC1CCC(C2(O)CCN(CC2)CCCC(=O)C2CCC(F)CC2)CC1.
Same parent
Under 51332500 · 27Activities that produce or sell this
KBLI · 8Inherited from family 51330000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.